tyrosine has been researched along with Brain Hemorrhage in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F | 1 |
| Bae, HJ; Chung, JW; Han, MK; Jang, MS; Jung, C; Kim, JH; Kim, KJ; Kwon, OK; Lee, J; Lee, JS; Noh, WY; Oh, CW; Yang, MH | 1 |
| Abraha, I; Ciccone, A; Cozzolino, F; Motto, C; Santilli, I | 1 |
| Chalouhi, N; Daou, B; Hasan, DM; Jabbour, P; Shields, B; Starke, RM | 1 |
| Boiti, C; Borutti, G; Cazzaniga, M; Falaschi, F; Maestroni, A; Mandelli, C; Manganaro, D; Monzani, V; Rossi, P; Torgano, G; Zecca, B; Zilioli, E | 1 |
| Fiebach, JB; Hamann, G; Hennerici, MG; Junghans, U; Röther, J; Schneider, D; Seitz, RJ; Siebler, M; Villringer, A; von Reutern, GM; Witte, OW | 1 |
| Bang, OY; Byun, HS; Jeon, P; Kim, GM; Kim, JW; Kim, KH | 1 |
| Cellerini, M; Gensini, G; Inzitari, D; Mangiafico, S; Nencini, P | 1 |
| Blankenship, JC; Frey, CM; Memon, MA; Menapace, FJ; Wood, GC | 1 |
2 review(s) available for tyrosine and Brain Hemorrhage
| Article | Year |
|---|---|
Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Brain Ischemia; Humans; Immunoglobulin Fab Fragments; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Tyrosine | 2014 |
Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.
Topics: Abciximab; Acetates; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Intracranial Hemorrhages; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine | 2000 |
2 trial(s) available for tyrosine and Brain Hemorrhage
| Article | Year |
|---|---|
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intracranial Hemorrhages; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recovery of Function; Stroke; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Stroke; Time Factors; Tirofiban; Tyrosine | 2011 |
5 other study(ies) available for tyrosine and Brain Hemorrhage
| Article | Year |
|---|---|
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2017 |
Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Atrial Fibrillation; Brain Ischemia; Combined Modality Therapy; Comorbidity; Female; Fibrinolytic Agents; Humans; Hypertension; Immunoglobulin Fab Fragments; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Mechanical Thrombolysis; Middle Aged; Neuroimaging; Prognosis; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Single-Blind Method; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2013 |
A New Protocol for Anticoagulation With Tirofiban During Flow Diversion.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clinical Protocols; Clopidogrel; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Intracranial Aneurysm; Intracranial Hemorrhages; Intraoperative Care; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tirofiban; Tyrosine | 2016 |
Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2012 |
Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Catheterization; Combined Modality Therapy; Female; Heparin; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Male; Middle Aged; Risk; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2005 |